Marisa holds an MS in Cellular and Molecular Pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. She specializes in cancer biology, immunology, and genetics. Marisa began working with BioNews in 2018, and has written about science and health for SelfHacked and the Genetics Society of America. She also writes/composes musicals and coaches the University of Pittsburgh fencing club.
Having a greater genetic likelihood for high blood pressure and obesity may correlate with a shorter lifespan, a large international study reports. This type of analysis could help identify ... Read more
A Phase 3 clinical trial testing setmelanotide as a treatment for insatiable hunger and severe obesity in people with Bardet-Biedl syndrome (BBS) and Alström syndrome has completed enrollment for its ... Read more
Mutations in the MRAP2 gene may increase the risk for obesity, high blood sugar, and hypertension, a large genetic study has found. The study, “Loss-of-function mutations in MRAP2 are pathogenic ... Read more
One-year treatment with setmelanotide in two Phase 3 trials significantly decreased the body mass index (BMI) of people with POMC deficiency or LEPR deficiency, two genetic obesity disorders. The data ... Read more
Carrying a genetic risk for obesity and high blood pressure is associated with a shorter lifespan, a study suggests. The study, “Trans-ethnic mega-biobank polygenic risk score analysis involving 676,000 ... Read more
A naturally occurring nonhuman primate model of Bardet-Biedl syndrome closely mimics the primary features of the condition in humans, including retinal and kidney anomalies, and may help researchers to ... Read more
Pin It on Pinterest